140 related articles for article (PubMed ID: 33476333)
1. Impaired tumor immune response in metastatic tumors is a selective pressure for neutral evolution in CRC cases.
Sakimura S; Nagayama S; Fukunaga M; Hu Q; Kitagawa A; Kobayashi Y; Hasegawa T; Noda M; Kouyama Y; Shimizu D; Saito T; Niida A; Tsuruda Y; Otsu H; Matsumoto Y; Uchida H; Masuda T; Sugimachi K; Sasaki S; Yamada K; Takahashi K; Innan H; Suzuki Y; Nakamura H; Totoki Y; Mizuno S; Ohshima M; Shibata T; Mimori K
PLoS Genet; 2021 Jan; 17(1):e1009113. PubMed ID: 33476333
[TBL] [Abstract][Full Text] [Related]
2. The rs6983267 SNP is associated with MYC transcription efficiency, which promotes progression and worsens prognosis of colorectal cancer.
Takatsuno Y; Mimori K; Yamamoto K; Sato T; Niida A; Inoue H; Imoto S; Kawano S; Yamaguchi R; Toh H; Iinuma H; Ishimaru S; Ishii H; Suzuki S; Tokudome S; Watanabe M; Tanaka J; Kudo SE; Mochizuki H; Kusunoki M; Yamada K; Shimada Y; Moriya Y; Miyano S; Sugihara K; Mori M
Ann Surg Oncol; 2013 Apr; 20(4):1395-402. PubMed ID: 22976378
[TBL] [Abstract][Full Text] [Related]
3. Elevated frequencies of CD8 T cells expressing PD-1, CTLA-4 and Tim-3 within tumour from perineural squamous cell carcinoma patients.
Linedale R; Schmidt C; King BT; Ganko AG; Simpson F; Panizza BJ; Leggatt GR
PLoS One; 2017; 12(4):e0175755. PubMed ID: 28423034
[TBL] [Abstract][Full Text] [Related]
4. Immunophenotyping of Newly Diagnosed and Recurrent Glioblastoma Defines Distinct Immune Exhaustion Profiles in Peripheral and Tumor-infiltrating Lymphocytes.
Mohme M; Schliffke S; Maire CL; Rünger A; Glau L; Mende KC; Matschke J; Gehbauer C; Akyüz N; Zapf S; Holz M; Schaper M; Martens T; Schmidt NO; Peine S; Westphal M; Binder M; Tolosa E; Lamszus K
Clin Cancer Res; 2018 Sep; 24(17):4187-4200. PubMed ID: 29444930
[No Abstract] [Full Text] [Related]
5. Preoperative Tim‑3 expression on peripheral NK cells is correlated with pathologic TNM staging in colorectal cancer.
Wang Y; Sun J; Gao W; Song B; Shao Q; Zhao L; Zhang Y; Wang Q; Zhang Y; Qu X
Mol Med Rep; 2017 Jun; 15(6):3810-3818. PubMed ID: 28440449
[TBL] [Abstract][Full Text] [Related]
6. The Prognostic Significance of the Tumor-infiltrating Programmed Cell Death-1
Shibutani M; Maeda K; Nagahara H; Fukuoka T; Nakao S; Matsutani S; Hirakawa K; Ohira M
Anticancer Res; 2017 Aug; 37(8):4165-4172. PubMed ID: 28739701
[TBL] [Abstract][Full Text] [Related]
7. Circulating and tumor-infiltrating Tim-3 in patients with colorectal cancer.
Xu B; Yuan L; Gao Q; Yuan P; Zhao P; Yuan H; Fan H; Li T; Qin P; Han L; Fang W; Suo Z
Oncotarget; 2015 Aug; 6(24):20592-603. PubMed ID: 26008981
[TBL] [Abstract][Full Text] [Related]
8. Impact of chromosomal instability on colorectal cancer progression and outcome.
Orsetti B; Selves J; Bascoul-Mollevi C; Lasorsa L; Gordien K; Bibeau F; Massemin B; Paraf F; Soubeyran I; Hostein I; Dapremont V; Guimbaud R; Cazaux C; Longy M; Theillet C
BMC Cancer; 2014 Feb; 14():121. PubMed ID: 24559140
[TBL] [Abstract][Full Text] [Related]
9. Relationship between T cell receptor clonotype and PD-1 expression of tumor-infiltrating lymphocytes in colorectal cancer.
Sukegawa K; Shitaoka K; Hamana H; Kobayashi E; Miyahara Y; Fujii K; Tsuda K; Saeki S; Nagata T; Ozawa T; Saito S; Fujii T; Muraguchi A; Shiku H; Kishi H
Eur J Immunol; 2020 Oct; 50(10):1580-1590. PubMed ID: 32441316
[TBL] [Abstract][Full Text] [Related]
10. Increased CD8 Tumor Infiltrating Lymphocytes in Colorectal Cancer Microenvironment Supports an Adaptive Immune Resistance Mechanism of PD-L1 Expression.
Sudoyo AW; Kurniawan AN; Kusumo GD; Putra TP; Rexana FA; Yunus M; Budiyati AD; Kurniawan D; Utama A; Utomo AR
Asian Pac J Cancer Prev; 2019 Nov; 20(11):3421-3427. PubMed ID: 31759368
[TBL] [Abstract][Full Text] [Related]
11. Copy number and transcriptome alterations associated with metastatic lesion response to treatment in colorectal cancer.
Gambaro K; Marques M; McNamara S; Couetoux du Tertre M; Diaz Z; Hoffert C; Srivastava A; Hébert S; Samson B; Lespérance B; Ko YJ; Dalfen R; St-Hilaire E; Sideris L; Couture F; Burkes R; Harb M; Camlioglu E; Gologan A; Pelsser V; Constantin A; Greenwood CMT; Tejpar S; Kavan P; Kleinman CL; Batist G
Clin Transl Med; 2021 Apr; 11(4):e401. PubMed ID: 33931971
[TBL] [Abstract][Full Text] [Related]
12. Expression of immune checkpoints and T cell exhaustion markers in early and advanced stages of colorectal cancer.
Saleh R; Taha RZ; Toor SM; Sasidharan Nair V; Murshed K; Khawar M; Al-Dhaheri M; Petkar MA; Abu Nada M; Elkord E
Cancer Immunol Immunother; 2020 Oct; 69(10):1989-1999. PubMed ID: 32393998
[TBL] [Abstract][Full Text] [Related]
13. Single-cell genetic analysis of clonal dynamics in colorectal adenomas indicates CDX2 gain as a predictor of recurrence.
Fiedler D; Heselmeyer-Haddad K; Hirsch D; Hernandez LS; Torres I; Wangsa D; Hu Y; Zapata L; Rueschoff J; Belle S; Ried T; Gaiser T
Int J Cancer; 2019 Apr; 144(7):1561-1573. PubMed ID: 30229897
[TBL] [Abstract][Full Text] [Related]
14. Tumor-associated macrophages and the tumor immune microenvironment of primary and recurrent epithelial ovarian cancer.
Ojalvo LS; Thompson ED; Wang TL; Meeker AK; Shih IM; Fader AN; Cimino-Mathews A; Emens LA
Hum Pathol; 2018 Apr; 74():135-147. PubMed ID: 29288043
[TBL] [Abstract][Full Text] [Related]
15. Dynamic monitoring the TCR CDR3 spectratypes in patients with metastatic CRC treated with a combination of bevacizumab, irinotecan, fluorouracil, and leucovorin.
Luo W; Liao WJ; Ma L; Huang YT; Shi M; Wen Q; Wang XN
Cancer Immunol Immunother; 2010 Feb; 59(2):247-56. PubMed ID: 19652968
[TBL] [Abstract][Full Text] [Related]
16. ST2 and regulatory T cells in the colorectal adenoma/carcinoma microenvironment: implications for diseases progression and prognosis.
Cui G; Yuan A; Li Z; Goll R; Florholmen J
Sci Rep; 2020 Apr; 10(1):5892. PubMed ID: 32246094
[TBL] [Abstract][Full Text] [Related]
17. Tim-3 is upregulated in human colorectal carcinoma and associated with tumor progression.
Yu M; Lu B; Liu Y; Me Y; Wang L; Zhang P
Mol Med Rep; 2017 Feb; 15(2):689-695. PubMed ID: 28035413
[TBL] [Abstract][Full Text] [Related]
18. Follicular helper T cells promote the effector functions of CD8
Shi W; Dong L; Sun Q; Ding H; Meng J; Dai G
Exp Cell Res; 2018 Nov; 372(1):35-42. PubMed ID: 30205088
[TBL] [Abstract][Full Text] [Related]
19. Tumor copy number alteration burden is a pan-cancer prognostic factor associated with recurrence and death.
Hieronymus H; Murali R; Tin A; Yadav K; Abida W; Moller H; Berney D; Scher H; Carver B; Scardino P; Schultz N; Taylor B; Vickers A; Cuzick J; Sawyers CL
Elife; 2018 Sep; 7():. PubMed ID: 30178746
[TBL] [Abstract][Full Text] [Related]
20. Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients.
Gros A; Parkhurst MR; Tran E; Pasetto A; Robbins PF; Ilyas S; Prickett TD; Gartner JJ; Crystal JS; Roberts IM; Trebska-McGowan K; Wunderlich JR; Yang JC; Rosenberg SA
Nat Med; 2016 Apr; 22(4):433-8. PubMed ID: 26901407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
